In an effort to reduce costs while maintaining high safety, efficacy, and quality standards, we are implementing new prior authorization (PA) requirements on select medical benefit oncology medications for members enrolled in Medicare Advantage plans. For members enrolled in these plans, select biosimilars will be the preferred medications.

Based on feedback received from prescribing providers related to notification review/preauthorization requirements for medical specialty drugs, Univera Healthcare will update its requirements for commercial fully insured members effective January 1, 2023.

The Univera Healthcare Participating Provider Manual has been updated and is now available on our website, UniveraHealthcare.com/policies/manuals. You will need to log in to the secure portion of the website to view the manual. Once logged in, you now have the option to view the entire manual or the individual sections.